Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigachi Industries is an active leading global manufacturer of microcrystalline cellulose (MCC) and other cellulose-based excipients, supplying major pharma and nutraceutical companies worldwide. Its R&D labs, USFDA/ISO recognized facilities, and robust export business enable Sigachi to offer high-quality, differentiated excipient products, with operations running at >95% capacity for its three main manufacturing plants, and significant capacity expansions underway.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sigachi Industries.